tradingkey.logo

Nuwellis Inc

NUWE
2.690USD
-0.078-2.83%
Cierre 11/04, 16:00ETCotizaciones retrasadas 15 min
33.76KCap. mercado
PérdidaP/E TTM

Más Datos de Nuwellis Inc Compañía

Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Información de Nuwellis Inc

Símbolo de cotizaciónNUWE
Nombre de la empresaNuwellis Inc
Fecha de salida a bolsaFeb 16, 2012
Director ejecutivoErb (John L)
Número de empleados38
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 16
Dirección12988 Valley View Rd
CiudadEDEN PRAIRIE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal55344
Teléfono19523454200
Sitio Webhttps://www.nuwellis.com/
Símbolo de cotizaciónNUWE
Fecha de salida a bolsaFeb 16, 2012
Director ejecutivoErb (John L)

Ejecutivos de Nuwellis Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
803.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
3.00
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
3.00
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
803.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
3.00
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
3.00
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--

Desglose de ingresos

Sin datos
Sin datos
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Sabby Management, LLC
0.67%
Bigger Capital Funds, LP
0.63%
UBS Financial Services, Inc.
0.36%
Geode Capital Management, L.L.C.
0.17%
XTX Markets LLC
0.08%
Otro
98.09%
Accionistas
Accionistas
Proporción
Sabby Management, LLC
0.67%
Bigger Capital Funds, LP
0.63%
UBS Financial Services, Inc.
0.36%
Geode Capital Management, L.L.C.
0.17%
XTX Markets LLC
0.08%
Otro
98.09%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
0.84%
Hedge Fund
0.72%
Investment Advisor
0.36%
Venture Capital
0.08%
Research Firm
0.02%
Individual Investor
0.02%
Otro
97.96%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
18
13.51K
2.03%
+10.13K
2025Q2
27
9.97K
1.46%
+7.11K
2025Q1
26
140.31K
3.15%
+23.64K
2024Q4
25
113.78K
2.60%
+73.44K
2024Q3
29
65.32K
2.68%
+45.76K
2024Q2
28
42.02K
3.15%
+30.15K
2024Q1
26
9.25K
4.91%
+1.97K
2023Q4
26
6.22K
6.75%
+3.61K
2023Q3
35
1.28K
4.82%
-1.76K
2023Q2
36
1.31K
5.00%
-797.00
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Sabby Management, LLC
3.52K
0.67%
+3.52K
--
Jun 30, 2025
Bigger Capital Funds, LP
5.69K
0.63%
+5.69K
--
Jun 09, 2025
UBS Financial Services, Inc.
1.88K
0.36%
+1.78K
+1797.98%
Jun 30, 2025
Geode Capital Management, L.L.C.
898.00
0.17%
+82.00
+10.05%
Jun 30, 2025
XTX Markets LLC
758.00
0.08%
+336.00
+79.62%
Jun 30, 2025
Two Sigma Investments, LP
415.00
0.08%
-23.00
-5.25%
Jun 30, 2025
Erb (John L)
803.00
0.02%
+803.00
--
Jun 10, 2025
Tower Research Capital LLC
132.00
0.01%
-14.00
-9.59%
Jun 30, 2025
Morgan Stanley & Co. LLC
126.00
0.01%
+126.00
--
Jun 30, 2025
SBI Securities Co., Ltd.
61.00
0.01%
+52.00
+577.78%
Jun 30, 2025
Ver más

ETFs relacionados

Nombre
Proporción
Sin datos

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Fecha
Tipo
Relación
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Oct 17, 2020
Merger
30→1
Oct 17, 2020
Merger
30→1
Ver más
KeyAI